| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 103,196 | 104,343 | 103,934 | 104,609 | | Cost of Revenue | 67,422 | 65,057 | 64,474 | 60,839 | | | Gross Profit | 35,774 | 39,286 | 39,460 | 43,770 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 31,538 | 35,069 | 36,300 | 40,661 | | Non Recurring |
-
| (3,459) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,167 | 7,676 | 3,160 | 3,109 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 349 |
-
| (183) | | Earnings Before Interest And Taxes | 6,775 | 6,754 | 4,431 | 3,409 | | Interest Expense | (882) | 669 | 213 |
-
| | Income Before Tax | 7,657 | 6,085 | 4,218 | 3,409 | | Income Tax Expense | 1,636 | 1,160 | (426) | 1,556 | | Minority Interest | (189) | (340) | (151) | (181) | | | | Net Income From Continuing Ops | 13,222 | 4,675 | 4,403 | 1,853 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,832 | 4,675 | 4,403 | 1,853 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,832 | $4,675 | $4,403 | $1,853 |
|
0.01% Nasdaq 
0.14 (2.08%) 
Income Statement
